Therapeutic potential of CCR1 antagonists for multiple myeloma.
about
CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone diseaseIdentifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays.C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.Are we just learning the scales on the chemokine receptor pianos?
P2860
Therapeutic potential of CCR1 antagonists for multiple myeloma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Therapeutic potential of CCR1 antagonists for multiple myeloma.
@en
Therapeutic potential of CCR1 antagonists for multiple myeloma.
@nl
type
label
Therapeutic potential of CCR1 antagonists for multiple myeloma.
@en
Therapeutic potential of CCR1 antagonists for multiple myeloma.
@nl
prefLabel
Therapeutic potential of CCR1 antagonists for multiple myeloma.
@en
Therapeutic potential of CCR1 antagonists for multiple myeloma.
@nl
P2860
P356
P1476
Therapeutic potential of CCR1 antagonists for multiple myeloma
@en
P2093
Angela R Karash
P2860
P304
P356
10.4155/FMC.11.144
P577
2011-11-01T00:00:00Z